This bill establishes a federal grant program to improve diabetes care in underserved urban and rural communities. It authorizes the Health Secretary to fund eligible providers - including community health centers, rural clinics, and tribal health departments - to deliver comprehensive services like routine diabetes treatment, prevention education, eye/foot care, and kidney disease management. Grants require providers to offer culturally appropriate care in local languages and conduct community outreach. Funding must be distributed equitably between urban and rural areas, with authorization for fiscal years 2026-2031. The program directly supports patients in medically underserved communities facing barriers to diabetes care.
Tags
Rural Communities
HR 5198, the Rural Health Clinic Location Modernization Act of 2025, changes Medicare eligibility rules for rural health clinics by updating the definition of "urban area" used to determine clinic qualification. It replaces the current "urbanized area" standard with a clearer definition: any urban area (per Census Bureau data) having a population of 50,000 or more. This adjustment directly affects clinics seeking Medicare certification, ensuring they meet consistent geographic criteria for rural designation. The change takes effect January 1, 2027, aiming to simplify qualification rules without altering Medicare coverage or benefits.
HR 685, the SAVE Moms and Babies Act of 2025, prohibits the FDA from approving new abortion drugs or allowing investigational use of existing ones. It restricts existing abortion drugs to in-person administration by certified healthcare providers in clinics or hospitals (not pharmacies), limits use to pregnancies under 70 days gestation, and requires providers to certify they can handle complications like severe bleeding or ectopic pregnancies. The bill mandates reporting of adverse events (such as hospitalizations or infections) to the FDA without patient identifiers and defines "abortion drug" broadly as any drug intended to terminate pregnancy, excluding specific medical exceptions. This directly affects FDA approval processes, healthcare providers prescribing these drugs, and drug manufacturers.
HR 7672, the Parity for Pacific Radiation Survivors Act, expands eligibility under the Radiation Exposure Compensation Act (RECA) for individuals exposed to radiation from Pacific nuclear tests. It adds Guam to the list of covered territories for claims and clarifies specific time periods for physical presence (e.g., July 1946-November 1992 or April-November 1962) or military cleanup participation (Enewetak Atoll, May 1977-May 1980). The bill also adds renal disease to the list of covered conditions and updates disease terminology to include "renal" alongside other illnesses. These changes directly affect Pacific Islanders, military personnel, and survivors who participated in or were exposed during specific nuclear testing periods. The amendments adjust existing RECA criteria to ensure broader access to compensation for qualifying radiation exposure claims.
The Tobacco TRACE Act requires the U.S. Food and Drug Administration (FDA) to establish a national tracking system for tobacco products by June 1, 2026. This system will monitor tobacco products throughout the supply chain - from manufacturers to retailers - to improve regulatory oversight. Tobacco manufacturers, distributors, and retailers will be directly affected, as they must provide product-level tracking data under the new system. The key provision mandates the FDA to implement this tracking framework to enhance enforcement of tobacco regulations.
HR 6764, the Veterans Affairs Advisory Committee Oversight Act of 2025, establishes four new advisory committees within the Department of Veterans Affairs to provide expert input on specific veteran needs. The bill creates a Veterans Health Advisory Committee focusing on prosthetics, mental health, and environmental exposures; a Veterans Economic Opportunity Committee addressing education and employment transitions; an Advisory Committee on Veterans Special Populations for underserved groups including women, tribal veterans, and those from outlying areas; and an Advisory Committee on Former Prisoners of War covering compensation and memorial affairs. Each committee must submit annual reports to VA leadership and Congress, with all committees set to terminate by September 30, 2028 unless renewed. The bill also terminates several existing advisory committees by September 30, 2026, streamlining the VA's advisory structure. This legislation does not create new benefits but establishes formal mechanisms for gathering expert input on existing VA programs.
Territories Health Equity Act of 2025 This bill alters provisions relating to the treatment of U.S. territories under Medicaid, Medicare, and Medicare Advantage. For example, the bill eliminates Medicaid funding limitations for U.S. territories beginning in FY2026, exempts an individual from late-enrollment penalties for Medicare medical services if the individual resided in Puerto Rico as of the date of eligibility and the individual enrolls within five years of such date, and establishes minimum criteria for certain elements used in Medicare Advantage payment calculations for areas within U.S. territories. The bill also allows residents of U.S. territories who are unable to obtain health insurance through their employer or a health insurance exchange to instead obtain coverage that is at least as broad as the coverage available to Members of Congress and their staff through the District of Columbia exchange.
This bill amends the SUPPORT for Patients and Communities Act to expand substance abuse and suicide prevention services for children, adolescents, and young adults (up to age 25). It requires eligible providers - like pediatric specialists, emergency departments, and children’s hospitals - to offer parents or guardians counseling on preventing overdose/suicide and provide supplies to reduce access to lethal means (e.g., safe storage containers). The bill allocates at least $2 million annually in grants to fund these prevention programs through eligible entities, with funding authorized for fiscal years 2026-2030. It directly affects young people at risk of substance misuse or self-harm and their caregivers.
S. 925 (Credit for Caring Act of 2025) creates a 30% tax credit for eligible family caregivers incurring qualified expenses to care for a certified relative with long-term care needs. It directly affects caregivers who earn over $7,500 annually and pay expenses exceeding $2,000 per year for care recipients certified by a healthcare professional as needing at least 180 days of care during the tax year. The credit covers costs like human assistance, home modifications, transportation, and respite care, with a maximum annual credit of $5,000 (adjusted for inflation). The credit phases out for taxpayers with modified adjusted gross income above $75,000 ($150,000 for joint filers). The bill applies to taxable years beginning after December 31, 2024.
HR 4084, the Access to Birth Control Act, requires pharmacies that stock contraception to provide it without delay when requested by a customer. If a requested method is out of stock, pharmacies must immediately offer referrals to nearby pharmacies or expedite an order. The bill prohibits pharmacists from intimidating customers, misrepresenting availability, breaching confidentiality, or refusing to fill valid prescriptions for contraception. It directly affects pharmacies nationwide, addressing reported refusals to provide birth control - particularly after the *Dobbs* decision - and ensures access to FDA-approved contraceptive methods without cost-sharing barriers.
